SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financial statements, including revenue, expenses, profit, and loss

The total revenue of 1349 for the last quarter is 150.41 M HKD, and it's 46.19% lower compared to the previous quarter. The net income of Q3 24 is 17.41 M HKD.